CB Insights just launched our Team of Agents — an AI workforce that saves months of work by instantly tackling research, due diligence, briefings, and more, so you can focus on high-impact decisions.
Their edge? Our agents are powered by CB Insights' proprietary Business Graph and double-verified intelligence — the same data that helps our customers grow revenue 48% faster.
Here's a snapshot of what our agents deliver:
ChatCBI — A general-purpose CB Insights agent, trained to surface and analyze the most relevant data and insight from CB Insights
Personal Briefing — Scours the news for your next big idea. It’s like a team of researchers working 24/7 just for you
Earnings Analyst — Delivers rapid-fire, CEO-ready competitive intel right after earnings calls
Business Relationship Analyst — Instant X-ray of customer, vendor, and partner relationships to reveal company strategy
Scouting Report Agent — Instant analyst-grade SWOT analyses on any private company
AI agent startups are becoming revenue machines at record speed.
Cursor (by Anysphere) reached $500M ARR just 2 years after founding, while Windsurf and Moveworks both crossed $100M before getting acquired.
And the capital efficiency is staggering — Mercor ($4.5M per employee) and Cursor ($3.2M per employee) exceeds Microsoft and Meta's revenue-per-employee metrics.
OpenAI and SoftBank's $500B Stargate project announced at the White House has struggled to launch, with not a single data center deal six months after promises of “immediate” AI infrastructure investment.
Meanwhile, Sam Altman has moved on without SoftBank, cutting his own deals:
$30B+ annual Oracle agreement starting within three years — consuming power equivalent to two Hoover Dams
A smaller CoreWeave investment — together nearly matching Stargate's promised capacity for this year
Big Pharma is spending $200B+ on US manufacturing, but it's not just about tariffs — it's about building AI-powered smart factories from scratch.
Major investments driving the buildout:
Johnson & Johnson: $55B — leading the pack in total commitments
AstraZeneca: $53.5B — including a $4B Virginia flagship facility
Roche: $50B — five-year manufacturing commitment
Eli Lilly: $50B — expansion plan since 2020
Novartis: $23B — over five years
AbbVie: $10B+ — multi-year U.S. investment
These investments will serve as testing grounds for large-scale AI deployment over the next several years, with companies that execute integrations most effectively gaining competitive advantages in efficiency and innovation.
P.S. Want to see how traditional banks are betting on blockchain? Check out our collaboration with Ripple and the UK Center for Blockchain Technologies.
CB Insights' emerging technology insights platform provides all the analysis and data from this newsletter. Our data is the easiest way to discover and respond to emerging tech.
